David Clapham

Title: David Clapham: Innovator in Pharmaceutical Chemistry

Introduction

David Clapham is a notable inventor based in Ware, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on crystalline forms of pyridine derivatives. His research has implications for therapeutic applications, showcasing the importance of his inventions in the medical field.

Latest Patents

David Clapham holds a patent for the invention titled "Crystalline forms of a pyridine derivative." This patent relates to the 4-methylbenzenesulfonate salt of a specific compound in crystalline form or a solvate thereof. The invention also encompasses pharmaceutical formulations containing these compounds, their therapeutic uses, and the processes for preparing them. This patent highlights his expertise and commitment to advancing pharmaceutical science.

Career Highlights

Throughout his career, David has been associated with GlaxoSmithKline LLC, a leading global healthcare company. His work at GlaxoSmithKline has allowed him to collaborate with other talented professionals in the field, further enhancing his contributions to pharmaceutical innovations.

Collaborations

David Clapham has worked alongside esteemed colleagues such as Clare Louise Anderton and Ronnie Maxwell Lawrence. These collaborations have fostered a productive environment for innovation and have led to advancements in their respective areas of expertise.

Conclusion

David Clapham's contributions to pharmaceutical chemistry through his patent and collaborations underscore his role as an influential inventor. His work continues to impact the field positively, paving the way for future innovations in medicine.